Biosimilars

Amgen Reports Results of ABP 654 (biosimilar, ustekinumab) in P-III Study for the Treatment of Plaque Psoriasis

Amgen Reports Results of ABP 654 (biosimilar, ustekinumab) in P-III Study for the Treatment of Plaque Psoriasis

Shots: The company reported the preliminary results from a P-III study to evaluate...

Amneal Receives the US FDA’s Approval for Alymsys (biosimilar, bevacizumab)

Amneal Receives the US FDA’s Approval for Alymsys (biosimilar, bevacizumab)

Shots: The US FDA has approved the BLA for bevacizumab-maly, a biosimilar referenc...

Image